摘要
目的观察血红素加氧酶-1(HO-1)及核转录因子kappa B(NF-κB)在大鼠矽肺纤维化中的作用机制及相互关系。方法实验动物采用Wistar大鼠60只,体重180~220g,雌雄不拘,适应性饲养1周后,随机分为4组,分别为对照组(A组)和染尘模型组(B组)、染尘+HO-1抑制剂组(C组)、染尘+HO-1诱导剂组(D组),每组15只。采用气管暴露法滴注二氧化硅悬液制造大鼠矽肺模型。建模28d后HE染色观察各组大鼠肺组织病理结构,采用Western blot法检测各组肺组织HO-1和NF-κB蛋白含量,采用荧光定量PCR法检测各组肺组织HO-1和NF-κB mRNA的表达。结果 Western blot检测结果显示HO-1、NF-κB蛋白含量,对照组明显低于其他各组(P〈0.05),C组较B组明显降低,而D组较B组表达量明显升高(P〈0.05)。RT-PCR检测各组HO-1mRNA相对表达量分别为2.25±0.38、1.81±0.74、7.75±0.56,C组较B组表达明显降低,而D组较B组表达显著升高(P〈0.05);NF-κB mRNA相对表达分别为3.06±0.42、6.15±0.37、1.39±0.14,C组较B组表达明显升高,而D组较B组表达显著降低(P〈0.05)。结论 HO-1、NF-κB共同参与了大鼠矽肺纤维化的形成过程,通过对其干预可以改变大鼠矽肺纤维化的程度,可为矽肺纤维化的诊断与治疗提供新途径。
Objective To observe the regulatory function of heme oxygenase 1(HO-1)and nuclear factor Kappa B(NF-κB)on the formation of pneumonoconiosis in rats. Methods Sixty Wistar rats weighted 80-220 g were randomly divided into 4groups after a week adaptive breeding.Rats in group A served as controls,while those in other groups were treated with dust(group B),plus HO-1inhibitor zinc protoporphyrin(group C),or HO-1inducer cobalt protoporphyrin(group D).Twenty-eight days after the rat model of silicosis was established,all rats were sacrificed and pathological changes of lung tissues were observed.Meanwhile,the expressions of HO-1and NF-κB in lung tissues of rats were detected using Western blot and real time quantitative PCR. Results The expressions of HO-1and NF-κB in lung tissues were the highest in group D,followed by those in group B,and the lowest in control group(P〈0.05).RT-PCR revealed that HO-1mRNA increased significantly from 2.25±0.38 in group B to 7.75±0.56 in group D,while it was the lowest of 1.81±0.74 in group C rats(P〈0.05).However,NF-κB mRNA was found to be the highest in group C(6.15±0.37)and the lowest in group D(1.39±0.14),it was 3.06±0.42 in rats of group B,the differences were statistically significant(P〈0.05). Conclusions Both HO-1and NF-κB involve in the process of idiopathic pulmonary fibrosis in rats,indicating that they may serve as intervention targets to provide new ways for pulmonary fibrosis diagnosis and therapy.
出处
《中国预防医学杂志》
CAS
2014年第5期490-494,共5页
Chinese Preventive Medicine
基金
山东省自然科学基金项目(ZR2011HL035)